Breast vascular mapping obtained with contrast-enhanced MR imaging: Implications for cancer diagnosis, treatment, and risk stratification

European Radiology, Supplement

Volumn 17, Issue SUPPL. 6, 2007, Pages

  Sardanelli, Francesco ^a   Fausto, Alfonso ^a   Menicagli, Laura ^a   Esseridou, Anastassia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast asymmetry; Breast cancer; Magnetic resonance (MR) angiography; Magnetic resonance (MR) imaging; Maximum intensity projections; Vascular mapping

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE; TAXANE DERIVATIVE;

ADVANCED CANCER; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER THERAPY; CARCINOMA IN SITU; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAMMOGRAPHY; METABOLIC RATE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VASCULAR RESISTANCE; VASCULARIZATION;

BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 40349089512     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-007-0228-3     Document Type: Article

References (12)

1. Sardanelli F, Iozzelli A, Fausto A (2002) Contrast agents and temporal resolution in breast MR imaging. J Exp Clin Cancer Res 21[Suppl 3]:69-75
2. Del Maschio A, Bazzocchi M, Giuseppetti GM et al (2002) Breast MRI: report on a multicentric national trial by the Study Section of Magnetic Resonance and Breast Imaging. Radiol Med 104:262-272
3. Mahfouz AE, Sherif H, Saad A et al (2001) Gadolinium-enhanced MR angiography of the breast: Is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 11:965-969
4. Carriero A, Di Credico A, Mansour M, Bonomo L (2002) Maximum intensity projection analysis in magnetic resonance of the breast. J Exp Clin Cancer Res 21(3 Suppl):77-81
5. Sardanelli F, Iozzelli A, Fausto A et al (2005) Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: Association between invasive cancer and ipsilateral increased vascularity. Radiology 235:791-797
6. Knopp MV, Bourne MW, Sardanelli F et al (2003) Gadobenate dimeglumine in contrast-enhanced magnetic resonance imaging of the breast: A dose response analysis and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol 181:663-676
7. Pediconi F, Catalano C, Occhiato R et al (2005) Breast lesion detection and characterization at contrast-enhanced MR mammography: Gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 237:45-56
8. Fausto A, Iozzelli A, Menicagli L, Sardanelli F (2006) Contrast enhanced MR imaging of the breast: One-side increased vasculature as a predictor of invasive cancer. Eur Radiol 16[Suppl 1]: 210
9. Cristofanilli M, Charnsangavej C, Hortobagyi GN (2002) Angiogenesis modulation in cancer research: Novel clinical approaches. Nat Rev Drug Discov 1:415-426
10. Esteva FJ, Sahin AA, Cristofanilli M et al (2002) Molecular prognostic factors for breast cancer metastasis and survival. Semin Radiat Oncol 12:319-328
11. Scutt D, Lancaster GA, Manning JT (2006) Breast asymmetry and predisposition to breast cancer. Breast Cancer Res 8:R14
12. Sardanelli F (2004) MultiHance for dynamic MR imaging of the breast. Eur Radiol 14[Suppl 7]:O65-O70